This independent retrospective case–control cohort study confirmed our prior discovery that somatic TP53 mutations are significantly more prevalent in grossly normal AEC specimens from cases with lung nodules diagnosed as cancer compared with controls with lung nodules confirmed to be benign (Fig. 1a). This evidence concerns the gene TP53 and cancer.